Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Case Study Life Sciences & Pharma Value Story and Cross-Stakeholder Action Plan for Oncology Reimbursement May 8, 2024 A big pharma company wanted to enable change in payer attitudes to increase the acceptance of patient-reported outcomes (PROs) and of endpoints beyond…
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Video / Webinar Life Sciences & Pharma L.E.K. Look Forward - L.E.K. Talent Focused Organisational Strategy December 13, 2023
Article Digital AI Has Moved Beyond Hype — It Is Driving Performance and Deployment Is Widespread September 20, 2023